Quince Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	6.45	6.21	20.75	44.58	69.72	66.84
Short-Term Investments	19.84	34.57	54.31	45.6	37.08	66.98
Cash & Short-Term Investments	26.29	40.78	75.06	90.18	106.8	133.82
Cash Growth	-45.06%	-45.66%	-16.77%	-15.56%	-20.19%	34.00%
Other Current Assets	2.91	3.25	2.38	3.57	4.87	4.04
Total Current Assets	29.2	44.04	77.44	93.75	111.67	137.86
Net Property, Plant & Equipment	1.1	0.81	0.62	0.68	1.43	1.1
Other Intangible Assets	67.73	60.05	63.67	5.9	-	-
Goodwill	-	-	17.63	-	-	-
Long-Term Investments	-	-	-	3.58	19.93	50.46
Other Long-Term Assets	11.87	9.58	8.54	-	0.19	0.04
Total Assets	109.9	114.48	167.9	103.91	133.23	189.47
Accounts Payable	3.4	2.9	2.03	0.57	4.91	3.56
Accrued Expenses	5.12	4.38	3.44	2.5	9.31	13.44
Current Portion of Long-Term Debt	17.52	-	-	-	-	-
Other Current Liabilities	-	-	4.1	-	-	-
Total Current Liabilities	26.04	7.28	9.57	3.07	14.22	17
Long-Term Debt	-	14.32	13.43	-	-	-
Long-Term Leases	0.36	0.39	0.32	-	0.42	0.21
Other Long-Term Liabilities	82.44	62.34	59.49	0.25	-	-
Total Long-Term Liabilities	82.8	77.05	73.24	0.25	0.42	0.21
Total Liabilities	108.84	84.33	82.82	3.32	14.64	17.2
Common Stock	0.05	0.04	0.04	0.04	0.03	0.03
Additional Paid-in Capital	415.71	406.61	401.64	389.11	355.23	318.57
Accumulated Other Comprehensive Income	6.29	-0.04	3.05	-0.29	-0.08	0.31
Retained Earnings	-420.99	-376.47	-319.64	-288.26	-236.6	-146.65
Shareholders' Equity	1.06	30.15	85.08	100.59	118.59	172.26
Total Liabilities & Equity	109.9	114.48	167.9	103.91	133.23	189.47
Total Debt	17.88	14.72	13.75	0	0.42	0.21
Net Cash (Debt)	8.41	26.07	61.31	90.18	106.38	133.61
Net Cash Growth	-67.74%	-57.48%	-32.02%	-15.23%	-20.38%	33.79%
Net Cash Per Share	0.18	0.60	1.65	2.69	3.58	4.58
Book Value	1.06	30.15	85.08	100.59	118.59	172.26
Book Value Per Share	0.02	0.70	2.28	3.00	3.99	5.90
Tangible Book Value	-66.67	-29.9	3.79	94.69	118.59	172.26
Tangible Book Value Per Share	-1.42	-0.69	0.10	2.83	3.99	5.90

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q